<code id='48D4EA0479'></code><style id='48D4EA0479'></style>
    • <acronym id='48D4EA0479'></acronym>
      <center id='48D4EA0479'><center id='48D4EA0479'><tfoot id='48D4EA0479'></tfoot></center><abbr id='48D4EA0479'><dir id='48D4EA0479'><tfoot id='48D4EA0479'></tfoot><noframes id='48D4EA0479'>

    • <optgroup id='48D4EA0479'><strike id='48D4EA0479'><sup id='48D4EA0479'></sup></strike><code id='48D4EA0479'></code></optgroup>
        1. <b id='48D4EA0479'><label id='48D4EA0479'><select id='48D4EA0479'><dt id='48D4EA0479'><span id='48D4EA0479'></span></dt></select></label></b><u id='48D4EA0479'></u>
          <i id='48D4EA0479'><strike id='48D4EA0479'><tt id='48D4EA0479'><pre id='48D4EA0479'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:42
          Christoph Lengauer stands for a portrait. -- biotech coverage from STAT
          Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

          Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

          The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

          advertisement

          “Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Florida Supreme Court upholds state's abortion ban
          Florida Supreme Court upholds state's abortion ban

          ANDREWCABALLERO-REYNOLDS/AFPviaGettyImagesTALLAHASSEE,Fla.—TheFloridaSupremeCourtonMondayupheldthest

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          How a symptom of dementia informs our understanding of creativity

          AnexampleofAnneAdams’artworkaftershewasdiagnosedwithFTD.VisualrepresentationofMauriceRavel’sBoléroCo